Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
John M. MaraganoreLocation
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Alnylam Pharmaceuticals is implementing good security practices.
Read more about the latest issues in cybersecurity
A man-in-the-middle attack (MITM attack) is a cyber attack where an attacker relays and possibly ...
The NIST Cybersecurity Framework provides a framework, based on existing standards, guidelines and ...
Compare Alnylam Pharmaceuticals's security performance with other companies